NIH-funded research R21 grant

Modifying harmful oral microbes with smart peptides guided by machine learning

Official title: Modifying microbial dysbiosis by machine learning guided species-biased antimicrobial peptides

Funded at University of Kansas Lawrence · NIH-11305025 · Data updated 2026-11-12

A study aims to use machine learning to guide the design of targeted antimicrobial peptides that reshape the oral microbiome to help treat periodontitis in teens and adults.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Lawrence
NIH-funded
Lab location1 site (Lawrence, United States)
Project startSeptember 4, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$252,275
NIH project number1R21DE034950-01A1
Project IDNIH-11305025 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adolescents or adults with periodontitis who consent to participate and provide oral samples for analysis.

Less likely to help

Patients without periodontal disease or those unwilling to share samples may not benefit.

What this research studies

This project focuses on periodontitis, an inflammatory gum disease linked to harmful bacteria in the mouth. Researchers will use machine learning to identify species-biased peptides that selectively target dysbiotic microbes while preserving beneficial ones. The work combines computational design with laboratory testing to steer the mouth’s microbial community back toward a healthy balance. If successful, it could reduce relapse and lessen the need for broad antibiotics or surgery. Participants would be adults or adolescents with periodontal disease, potentially contributing samples or data to refine the approach.

Why it matters

Potential benefit: If successful, this approach could lead to more precise, less disruptive treatments for periodontitis and reduce relapse risk.

How similar studies have gone: Previous work shows promise in targeting specific oral bacteria; this project extends those concepts with machine learning-guided, species-specific peptides.

Where this research is happening

  • University of Kansas Lawrence
    Lawrence, United States
    Active

Researchers

  • Principal investigator: Tamerler-Behar, Candan — University of Kansas Lawrence
  • Study coordinator: Tamerler-Behar, Candan

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.